FUSID: Prevalence and Natural History of Functional Gastrointestinal Disorders Among At-risk Infants.

Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Other)
Overall Status
Recruiting
CT.gov ID
NCT06031025
Collaborator
(none)
71
1
19.4
3.7

Study Details

Study Description

Brief Summary

The goal of this observational study is to learn about the prevalence and characteristics of functional gastrointestinal disorders (FGID) in at risk infants (former preterm infants and those with birth asphyxia) during the first 2 years of life. The main questions it aims to answer are:

  • evaluate the prevalence of symptoms related to GER, of functional gastrointestinal disorders during the first 2 years of life

  • describe growth parameters during follow-up up to the corrected age of 2 years Participants will be assessed clinically and with a structured questionnaire based on the Rome IV criteria to describe FGID.

Condition or Disease Intervention/Treatment Phase
  • Other: Questionnaire, clinical examination

Detailed Description

Infants will undergo clinical assessment at 3, 6, 12, 24 months' corrected age at the local Follow-up clinic.

Clinical examination, anthropometric measurement and data from a structured questionnaire to detect FGID will be performed.

Z-scores for weight, length and head circumference will be calculated according to the WHO standards.

Data from the questionnaires will be collected. Clinical characteristics of patients and perinatal data will be collected and analyzed by appropriate statistical methods.

The prevalence and characteristics of FGID in the study population will be compared to published data (mostly from term infants).

Study Design

Study Type:
Observational
Anticipated Enrollment :
71 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Prospective Assessment of the Prevalence and Natural History of Gastroesophageal Reflux and Functional Gastro-intestinal Disorders Among At-risk Infants
Actual Study Start Date :
May 20, 2022
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Outcome Measures

Primary Outcome Measures

  1. Prevalence and characteristics of FGID [3, 6, 12, 24 months of corrected age]

    Occurrence of FGID (percentage of patients)

  2. Prevalence and characteristics of FGID [3, 6, 12, 24 months of corrected age]

    Frequency of FGID (i.e. number of symtoms per day)

  3. Prevalence and characteristics of FGID [3, 6, 12, 24 months of corrected age]

    Severity (scales from 0 to 10 for increasing values) of FGID

Secondary Outcome Measures

  1. Somatic growth: weight [3, 6, 12, 24 months of corrected age]

    Measurement of weight and calculation of z-scores based on reference standards by the World Health Organization

  2. Somatic growth: head circumference [3, 6, 12, 24 months of corrected age]

    Measurement of head circumference and calculation of z-scores based on reference standards by the World Health Organization

  3. Somatic growth: length [3, 6, 12, 24 months of corrected age]

    Measurement of length and calculation of z-scores based on reference standards by the World Health Organization

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Months to 24 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • infants with gestational age at birth < 31 weeks

  • infants with gestational age at birth < 37 weeks and major respiratory or neurologic morbidity

  • infants with history of perinatal asphyxia

Exclusion Criteria:
  • lack of informed consent

  • diagnosis of congenital or other major gastrointestinal disease (i.e. inflammatory bowel disease, cancer)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Fondazione Policlinico Gemelli IRCCS Roma Italy 00168

Sponsors and Collaborators

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Investigators

  • Principal Investigator: Stefano Nobile, MD, PhD, MSc, Fondazione Policlinico Universitario A. Gemelli, IRCCS

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
ClinicalTrials.gov Identifier:
NCT06031025
Other Study ID Numbers:
  • 4921
First Posted:
Sep 11, 2023
Last Update Posted:
Sep 11, 2023
Last Verified:
Sep 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 11, 2023